World's Best Scientists 2026 revealed!
Cancer Treatment Reviews
H-index 55

Cancer Treatment Reviews

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 196 281 287 54

Additional Metrics

Number of Best Scientists*: 335
Documents by Best Scientists*: 322
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 172
SCIMAGO SJR: 4.183
Impact Factor: 10.5

Overview

Top Research Topics at Cancer Treatment Reviews?

Cancer Treatment Reviews aims to foster the development of research in Internal medicine, Oncology, Cancer, Chemotherapy and Cancer research. Internal medicine research discussed connects with the study of Surgery. Cancer Treatment Reviews explores research in Oncology alongside concepts in Randomized controlled trial and other areas of study in Meta-analysis.

The Cancer works featured in the journal incorporate elements from Pharmacology and Intensive care medicine. Cancer Treatment Reviews dives deep in exploring the relationship between the study of Pharmacology and Toxicity. The study on Chemotherapy presented is investigated in conjunction with research in Pathology.

While Cancer Treatment Reviews focused on Cancer research, it was also able to explore topics like Cancer cell and Immunology. In the Breast cancer research discussed, Tamoxifen, Trastuzumab and Metastatic breast cancer are all tackled. The journal focused on Immunotherapy research conducted under the discipline of Immune system.

  • Internal medicine (49.11%)
  • Oncology (43.98%)
  • Cancer (22.63%)

What are the most cited papers published in the journal?

  • PI3K/Akt signalling pathway and cancer ☆ (1450 citations)
  • Metastatic bone disease: clinical features, pathophysiology and treatment strategies. (1363 citations)
  • Molecular mechanisms of resistance and toxicity associated with platinating agents. (1153 citations)

Research areas of the most cited articles at Cancer Treatment Reviews:

The most cited papers primarily tackle Internal medicine, Oncology, Cancer, Cancer research and Pharmacology. The Internal medicine research presented in the journal publications focuses mostly on Surgery and, on occasion, topics in Meta-analysis. While work presented in the journal publications provide substantial information on Cancer, it also covers topics in Radiation therapy and Intensive care medicine.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Chemotherapy

The previous edition focused in particular on these issues:

The journal explores disciplines such as Internal medicine, Oncology, Clinical trial, Cancer and Chemotherapy. The presented Internal medicine study covers related areas such as Meta-analysis, Breast cancer and Randomized controlled trial and also touches on topics like In patient. The research on Oncology tackled can also make contributions to studies in the areas of Radiation therapy, Adverse effect, Disease and Hazard ratio.

Cancer Treatment Reviews deals with Clinical trial in conjunction with other fields like

  • Immunotherapy, which have a strong connection to Cancer research and Malignancy,
  • Precision medicine which connect with Personalization.. While work presented in it provided substantial information on Cancer, it also covered topics in Young adult, Guideline, Chronic liver disease, Pediatrics and Monoclonal antibody. While Chemotherapy is the focus of the journal, it also provided insights into the studies of Colorectal cancer, Quality of life and Trastuzumab.

The most cited articles from the last journal are:

  • Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors – A systematic review and meta-analysis (21 citations)
  • MEK inhibitor resistance mechanisms and recent developments in combination trials. (13 citations)
  • MYC as a target for cancer treatment. (12 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Cancer Treatment Reviews (based on the number of publications) are:

  • Robert E. Coleman (43 papers) absent at the last edition,
  • Eitan Amir (26 papers) published 4 papers at the last edition, 1 more than at the previous edition,
  • Nicholas Pavlidis (23 papers) absent at the last edition,
  • Jos H. Beijnen (22 papers) absent at the last edition,
  • Benjamin Djulbegovic (22 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer Treatment Reviews (based on the number of publications) are:

  • University of Texas MD Anderson Cancer Center (75 papers) published 2 papers at the last edition, 4 less than at the previous edition,
  • European Institute of Oncology (63 papers) published 12 papers at the last edition, 7 more than at the previous edition,
  • Netherlands Cancer Institute (59 papers) published 3 papers at the last edition the same number as at the previous edition,
  • The Royal Marsden NHS Foundation Trust (51 papers) published 3 papers at the last edition, 1 more than at the previous edition,
  • Harvard University (51 papers) published 4 papers at the last edition, 1 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 4.81% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 33.33% were posted by at least one author from the top 10 institutions publishing in the journal. Another 18.18% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.11% of all publications and 37.37% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Pursuing a Career in Cancer Research

Pivotal to making improvements in cancer treatment and therapies is the role of medical professionals and researchers specializing in oncology. A career in this field often starts with obtaining specific education and training. For example, becoming a nurse practitioner specializing in cancer research involves rigorous educational preparation and understanding of oncology, pharmacology, immunology, and more. If you're considering embarking on this career path, gaining an understanding of the specific education and training requirements is crucial. For those based in the Granite State, reviewing the nurse practitioner education requirements in New Hampshire would be highly beneficial. As a nurse practitioner, your role can extend beyond clinical practice into the realm of research, contributing significantly to areas such as internal medicine, chemotherapy, immunotherapy and more. Moreover, nurse practitioners can be involved in clinical trials and studies, contributing to the publications we review and analyze in these reports. Therefore, pursuing a nursing career with a focus on oncology offers a rewarding path for those wanting to contribute to the crucial fight against cancer and the continuous pursuit of more effective and personalized treatment methods.

Top Publications

  • Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook.

    Josep Garcia;Herbert I. Hurwitz;Alan B. Sandler;David Miles

    (2020)
    823 Citations
  • Review of precision cancer medicine: Evolution of the treatment paradigm.

    Apostolia M. Tsimberidou;Elena Fountzilas;Mina Nikanjam;Razelle Kurzrock

    (2020)
    460 Citations
  • MYC as a target for cancer treatment.

    Michael J Duffy;Shane O'Grady;Minhong Tang;John Crown

    (2021)
    287 Citations
  • The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target

    V. Gambardella;J. Castillo;N. Tarazona;F. Gimeno-Valiente

    (2020)
    232 Citations
  • Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy.

    (2022)
    208 Citations
  • KRAS: From undruggable to a druggable Cancer Target

    Dipesh Uprety;Alex A. Adjei

    (2020)
    195 Citations
  • Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality

    (2022)
    182 Citations
  • Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives.

    (2022)
    164 Citations
  • KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?

    Misako Nagasaka;Yiwei Li;Ammar Sukari;Sai-Hong Ignatius Ou

    (2020)
    163 Citations
  • Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management.

    (2022)
    159 Citations

Related Online Degrees & Career Pathways

Exploring alternative or complementary educational paths can enhance your medical career options in the USA. For those interested in support roles within healthcare, online medical assistant programs with financial aid provide accessible pathways to build foundational clinical skills without the need for on-campus attendance.

Many medical assistants aim to advance their careers further. The ma to lpn bridge program online offers a streamlined route to become a Licensed Practical Nurse, opening doors to more specialized responsibilities and higher earning potential.

For students wanting a solid scientific background to eventually enter medicine, pursuing online biology degree programs can be an effective preparatory step, especially when balancing studies with other commitments.

Nursing careers remain vital in the healthcare system. The online ASN offers an accessible entry point into nursing, combining flexibility with comprehensive clinical training crucial for licensure and practice.

Understanding these related degrees and career pathways not only broadens your options but also helps tailor your education to best fit your professional aspirations within the medical field.

Best Scientists Contributing to This Journal

Recently Published Articles